```text
══════════════════════════════════════════════════════
QUANTITATIVE EQUITY SELECTION REPORT — 2026-06-30
Run Status: NO_TRADE
Classification: INTERNAL — INVESTMENT COMMITTEE USE
══════════════════════════════════════════════════════
```

Model `claude-opus-4-8` · Data mode **LIVE** · Horizon 2–6 weeks (target 2026-07-28).

## Executive Summary

The tape is a BULL market with violent internal rotation: SPY is above all moving averages (60d +13.8%) but the last month rotated **out of** mega-cap growth/AI-software (MSFT, NOW, PLTR, NFLX, META down 12–25% MoM) **into** healthcare, financials, industrials, and semis/memory. Factor scoring cleanly surfaces a defensive-quality leadership cohort (UNH, V, LLY, BAC), but only **4 names clear the full investability gate (< 5 minimum)**, and those names carry rotation-distorted low/negative 60d betas so that the **maximum achievable long-book beta (0.03–0.59) cannot reach the 0.90 floor** under the protected 5% single-name cap. The result is **NO_TRADE** — no constraint-compliant portfolio exists — and the ranked names are published as paper monitoring forecasts (settle 2026-07-28). This is the 16th consecutive cross-model NO_TRADE in this environment, driven by the same beta-band-vs-rotation mechanism (routed to evolution).

## MoM Reflection Summary (from 02)

Baseline `gemini-3-5-flash-2026-05-30` (ILLUSTRATIVE, CROSS_MODEL_BASELINE). 0 predictions settled (none matured; earliest 2026-07-08). Grounded MoM on the baseline's 8 picks: defensive-quality won (LLY +10.8% α, UNH +10.8%, GE +16.3%, LIN +5.8%) and mega-cap growth lost (NOW −20.2% α, AVGO −14.3%, NFLX −14.0%, META −10.5%) — alpha hit-rate 4/8. The rotation read is corroborated by today's independent scores; `CARRY` LLY/UNH/GE/LIN, `DROP` META/NFLX/AVGO/NOW.

## Regime (from 03)

| Regime | Data Quality | Key Macro Risk | Ledger |
|---|---|---|---|
| **BULL (extended, rotating)** | LIVE; DQ 0.80 (proxy Fund/Sent families) | Monthly RSI extended (SPY 72/QQQ 77/SOXX 89); semis at TD9-9 exhaustion; Q2 earnings season opens inside horizon | L201–L303 |

## Core ETF Market Forecast (from 03 — no new facts)

| ETF | Entry | mu | sigma | Target | 70% CI | Conf |
|---|---|---|---|---|---|---|
| SPY | 745.17 | +1.5% | 4.4% | 756.35 | 721.94–790.76 | MEDIUM |
| QQQ | 734.34 | +2.35% | 8.2% | 751.60 | 688.90–814.30 | MEDIUM |
| SOXX | 636.03 | +3.26% | 20.5% | 656.76 | 520.96–792.56 | LOW (TD9-9 + RSI 89 exhaustion) |

## Ranked Candidates (from 05 — compact)

| Tkr | Adj | Pctl | mu/σ | Beta | Gate | Conf | Thesis · Key risk |
|---|---|---|---|---|---|---|---|
| UNH | 0.71 | 100 | +6.0/7.6 | −0.16 | **INVEST** | LOW | Healthcare-leadership mean-reversion · Q2 ~15d, TD9-9 |
| AMD | 0.59 | 97 | +6.0/22 | 3.87 | reject | LOW | Memory/AI momentum · β3.9, momentum-only |
| V | 0.43 | 94 | +5.0/5.7 | −0.01 | **INVEST** | MEDIUM | Payments quality, best IR 0.71 · negative-β rotation |
| LLY | 0.42 | 91 | +5.0/10 | 0.22 | **INVEST** | LOW | GLP-1 franchise · rate sensitivity, TD9-9 |
| BAC | 0.41 | 89 | +4.0/5.3 | 0.32 | **INVEST** | LOW | Bank rotation leader · Q2 ~15d |
| CAT | 0.41 | 86 | +4.0/14 | 1.93 | reject | LOW | Cyclical momentum · RSI 86 overbought |
| MU | 0.31 | 83 | +3.0/35 | 4.16 | reject | LOW | Memory super-cycle · RSI 92, IR −0.14 (peak exhaustion) |
| GE | 0.30 | 80 | +3.0/9.0 | 1.25 | reject | LOW | Aerospace cycle · TD9-9, Sent_Z neg |
| SO·LIN·JPM·JNJ·HD·TSLA·PG | 0.14–0.29 | 60–77 | +1–2% | mixed | monitor | LOW/MED | Monitoring sleeve (settleable forecasts) |

Investable gate clears only UNH/V/LLY/BAC (balanced 4-family, no family > 50% conviction). AMD/CAT/MU/GE are momentum-concentrated (Tech_Z 55–85% of conviction) and exhausted.

## No-Trade Rationale (from 07/08)

Two protected-rule triggers, each sufficient: (1) **< 5 investable names**; (2) **beta band [0.90, 1.10] infeasible** — max achievable long-book beta is 0.59 (all ≥80th names) / 0.03 (full-gate set) under the 5% cap, because every investable-grade quality name has rotation-distorted low/negative 60d beta and the only high-beta names fail the quality gate. Correlation (0.05), drawdown, and single-name caps are all satisfiable — beta is the sole blocker. Risk committee **confirmed NO_TRADE**; no portfolio forced.

## Assumptions and Limitations

- Fundamental and Sentiment families are **price-based proxies** (no fundamentals/short-interest/options/analyst feed) → DQ 0.80, confidence ≤ MEDIUM, cross-family momentum overlap.
- Risk-free rate not sourced → Sharpe/Sortino/Treynor are `RAW_DIAGNOSTIC`.
- 60d betas are rotation-distorted (unstable); ETF betas (QQQ 1.56, SOXX 3.17) are inflated upper bounds.
- Broad-universe prices are same-session Yahoo validated within 0.30% of IBKR on a 7-name sample; per-name dual-sourcing limited to the ETF sleeve + sample (acceptable for a paper/NO_TRADE run).
- Earnings dates are cadence-estimated `ESTIMATED (±5d)`.
- 0 settled predictions in system history → calibration `INSUFFICIENT_SETTLED_N` (first maturity ~2026-07-08).

## Next Scheduled Review

Midday monitor 12:15 ET, pre-close 15:45 ET, close log 16:20 ET (2026-06-30). Monthly structural review due today (last trading day of June) → `16_monthly_review.md`. Next full pre-open pipeline: 2026-07-01 07:27 ET. First prediction settlement wave: ~2026-07-08.
